Type | Indexed | Publication . Mgi Jnum | J:243362 |
Publication . Citation | Zhou M, et al. (2017) The anti-diabetic drug exenatide, a glucagon-like peptide-1 receptor agonist, counteracts hepatocarcinogenesis through cAMP-PKA-EGFR-STAT3 axis. Oncogene 36(29):4135-4149 |